Clinical Study

Efficacy of High-Dose and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcomes in Patient with Acute Ischemic Stroke: A Randomized, Double-Blind, Parallel, Controlled Trial

Table 3

Serum sLOX-1 and NO levels in patient with acute ischemic stroke received simvastatin therapy for 90 days.

ParameterSimvastatin 10 mg (N = 34)
Mean ± SD
Simvastatin 40 mg (N = 31)
Mean ± SD
value

sLOX-1 levels (ng/ml)1.19 ± 0.470.98 ± 0.370.04
NO levels (µmol/l)49.28 ± 7.2146.59 ± 9.360.2